50% Price cut announced for Wegovy, Ozempic, and Rybelsus will impact New Jersey patients
PLAINSBORO, NJ – In a move expected to benefit thousands of New Jersey residents living with obesity and type 2 diabetes, Novo Nordisk, whose U.S. headquarters is based in Plainsboro, announced it…